ER stress-mediated apoptosis in a new mouse model of Osteogenesis imperfecta

PLoS Genetics

Volumn 4, Issue 2, 2008, Pages

  Lisse, Thomas S ^a,e   Thiele, Frank ^a   Fuchs, Helmut ^a   Hans, Wolfgang ^a   Przemeck, Gerhard K H ^a   Abe, Koichiro ^a,f   Rathkolb, Birgit ^a,b   Quintanilla Martinez, Leticia ^a   Hoelzlwimmer, Gabriele ^a   Helfrich, Miep ^c   Wolf, Eckhard ^b   Ralston, Stuart H ^d   De Angelis, Martin Hrabé ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 12; CASPASE 3; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN 47; PROCOLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN; DNA;

AGA2 GENE; APOPTOSIS; ARTICLE; BONE TURNOVER; COL1A1 GENE; CONTROLLED STUDY; GENE; MOLECULAR CLONING; MOUSE; NONHUMAN; OSTEOGENESIS IMPERFECTA; AMINO ACID SEQUENCE; ANIMAL; DISEASE MODEL; ENDOPLASMIC RETICULUM; FEMALE; FRAMESHIFT MUTATION; GENETICS; HETEROZYGOTE; HUMAN; LETHAL GENE; MALE; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PATHOLOGY; PHENOTYPE; PREGNANCY;

ANIMALIA;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; DNA; ENDOPLASMIC RETICULUM; FEMALE; FRAMESHIFT MUTATION; GENES, LETHAL; HETEROZYGOTE; HUMANS; MALE; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; OSTEOGENESIS IMPERFECTA; PHENOTYPE; PREGNANCY;

EID: 40149105885     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0040007     Document Type: Article

References (56)

1. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, et al. (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28: 209-221.
2. Aubin I, Adams CP, Opsahl S, Septier D, Bishop CE, et al. (2005) A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet 37: 803-805.
3. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, et al. (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127: 291-304.
4. Barnes AM, Chang W, Morello R, Cabral WA, Weis M, et al. (2006) Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 355: 2757-2764.
5. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, et al. (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39: 359-365.
6. Myllyharju J, Kivirikko KI (2004) Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 20: 33-43.
7. Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L, San Antonio JD (2002) Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 277: 4223-4231.
8. Alford AI, Hankenson KD (2006) Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration. Bone 38: 749-757.
9. Cole WG, Dalgleish R (1995) Perinatal lethal osteogenesis imperfecta. J Med Genet 32: 284-289.
10. Edwards MJ, Wenstrup RJ, Byers PH, Cohn DH (1992) Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease. Hum Mutat 1: 47-54.
11. Chessler SD, Byers PH (1993) BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta. J Biol Chem 268: 18226-18233.
12. Lamande SR, Chessler SD, Golub SB, Byers PH, Chan D, et al. (1995) Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly. J Biol Chem 270: 8642-8649.
13. Fitzgerald J, Lamande SR, Bateman JF (1999) Proteasomal degradation of unassembled mutant type I collagen pro-alpha1(I) chains. J Biol Chem 274: 27392-27398.
14. Hrabe de Angelis MH, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D, et al. (2000) Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 25: 444-447.
15. Lees JF, Tasab M, Bulleid NJ (1997) Identification of the molecular recognition sequence which determines the type-specific assembly of procollagen. EMBO J 16: 908-916.
16. Gailus-Durner V, Fuchs H, Becker L, Bolle I, Brielmeier M, et al. (2005) Introducing the German Mouse Clinic: Open access platform for standardized phenotyping. Nat Methods 2: 403-404.
17. Stacey A, Bateman J, Choi T, Mascara T, Cole W, et al. (1988) Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene. Nature 332: 131-136.
18. Khillan JS, Olsen AS, Kontusaari S, Sokolov B, Prockop DJ (1991) Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta. J Biol Chem 266: 23373-23379.
19. Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC (1999) Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J Biol Chem 274: 37923-37931.
20. Rauch F, Travers R, Parfitt AM, Glorieux FH (2000) Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 26: 581-589.
21. Cole WG (2002) Advances in osteogenesis imperfecta. Clin Orthop Relat Res: 6-16.
22. Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363: 1377-1385.
23. Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, et al. (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone 34: 1013-1016.
24. Bruckner P, Prockop DJ (1981) Proteolytic enzymes as probes for the triple-helical conformation of procollagen. Anal Biochem 110: 360-368.
25. Canty EG, Kadler KE (2005) Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 118: 1341-1353.
26. Bateman JF, Lamande SR, Dahl HH, Chan D, Mascara T, et al. (1989) A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta. J Biol Chem 264: 10960-10964.
27. Bateman JF, Chan D, Mascara T, Rogers JG, Cole WG (1986) Collagen defects in lethal perinatal osteogenesis imperfecta. Biochem J 240: 699-708.
28. Chessler SD, Wallis GA, Byers PH (1993) Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta. J Biol Chem 268: 18218-18225.
29. Peltonen L, Palotie A, Prockop DJ (1980) A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: Excess mannose in the COOH-terminal propeptide. Proc Natl Acad Sci U S A 77: 6179-6183.
30. Willing MC, Cohn DH, Byers PH (1990) Frameshift mutation near the 3′ end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. J Clin Invest 85: 282-290.
31. Prockop DJ (1984) Osteogenesis imperfecta: Phenotypic heterogeneity, protein suicide, short and long collagen. Am J Hum Genet 36: 499-505.
32. Delahunty M, Bonifacino JS (1995) Disorders of intracellular protein trafficking in human disease. Connect Tissue Res 31: 283-286.
33. Lamande SR, Bateman JF (1999) Procollagen folding and assembly: The role of endoplasmic reticulum enzymes and molecular chaperones. Semin Cell Dev Biol 10: 455-464.
34. Yoshida H (2007) ER stress and diseases. FEBS J 274: 630-658.
35. Flynn GC, Pohl J, Flocco MT, Rothman JE (1991) Peptide-binding specificity of the molecular chaperone BiP. Nature 353: 726-730.
36. Ripley CR, Bienkowski RS (1997) Localization of procollagen I in the lysosome/endosome system of human fibroblasts. Exp Cell Res 236: 147-154.
37. Kojima T, Miyaishi O, Saga S, Ishiguro N, Tsutsui Y, et al. (1998) The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta. J Pathol 184: 212-218.
38. Schafer ZT, Kornbluth S (2006) The apoptosome: Physiological, developmental, and pathological modes of regulation. Dev Cell 10: 549-561.
39. Nakagawa T, Yuan J (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150: 887-894.
40. Morishima N, Nakanishi K, Tsuchiya K, Shibata T, Seiwa E (2004) Translocation of Bim to the endoplasmic reticulum (ER) mediates ER stress signaling for activation of caspase-12 during ER stress-induced apoptosis. J Biol Chem 279: 50375-50381.
41. Rao RV, Peel A, Logvinova A, del Rio G, Hermel E, et al. (2002) Coupling endoplasmic reticulum stress to the cell death program: Role of the ER chaperone GRP78. FEBS Lett 514: 122-128.
42. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 21: 1249-1259.
43. Forlino A, Tani C, Rossi A, Lupi A, Campari E, et al. (2007) Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta. Proteomics 7: 1877-1891.
44. Bernstein EF, Chen YQ, Kopp JB, Fisher L, Brown DB, et al. (1996) Long-term sun exposure alters the collagen of the papillary dermis. Comparison of sun-protected and photoaged skin by northern analysis, immunohistochemical staining, and confocal laser scanning microscopy. J Am Acad Dermatol 34: 209-218.
45. Klempt M, Rathkolb B, Fuchs E, de Angelis MH, Wolf E, et al. (2006) Genotype-specific environmental impact on the variance of blood values in inbred and F1 hybrid mice. Mamm Genome 17: 93-102.
46. Fuchs H, Lisse T, Abe K, Hrabe de Angelis M (2006) Screening for bone and cartilage phenotypes in mice. In: Hrabe de Angelis M, Chambon P, Brown S, editors. Standards of mouse model phenotyping. 1st edition. Weinheim (Germany): Wiley-VCH Verlag GmbH. pp. 35-86.
47. Abe K, Fuchs H, Lisse T, Hans W, Hrabe de Angelis M (2006) New ENU-induced semidominant mutation, Ali18, causes inflammatory arthritis, dermatitis, and osteoporosis in the mouse. Mamm Genome 17: 915-926.
48. Peters DD, Marschall S, Mahabir E, Boersma A, Heinzmann U, et al. (2006) Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes. Biol Reprod 74: 246-252.
49. Rodriguez N, Fend F, Jennen L, Schiemann M, Wantia N, et al. (2005) Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction. J Immunol 174: 4836-4844.
50. van't Hof RJ, Macphee J, Libouban H, Helfrich MH, Ralston SH (2004) Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology 145: 5068-5074.
51. Miao D, Scutt A (2002) Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 50: 333-340.
52. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
53. Chipman SD, Sweet HO, McBride DJ Jr, Davisson MT, Marks SC Jr, et al. (1993) Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: A model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A 90: 1701-1705.
54. Gerber I, ap Gwynn I (2001) Influence of cell isolation, cell culture density, and cell nutrition on differentiation of rat calvarial osteoblast-like cells in vitro. Eur Cell Mater 2: 10-20.
55. Tsuang YH, Sun JS, Chen LT, Sun SC, Chen SC (2006) Direct effects of caffeine on osteoblastic cells metabolism: The possible causal effect of caffeine on the formation of osteoporosis. J Orthop Surg 1: 7.
56. Machka C, Kersten M, Zobawa M, Harder A, Horsch M, et al. (2005) Identification of Dll1 (Delta1) target genes during mouse embryogenesis using differential expression profiling. Gene Expr Patterns 6: 94-101.